Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Self-Injurious Behavior in BPD
NCT00539188Phase 2Terminated
- Sponsor
- Yale University
- Start
- Sep 2007
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in borderline personality disorder (BPD), sponsored by Yale University. Started Sep 2007; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT00539188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539188.